Literature DB >> 30562025

Enantioselective Biocatalytic Reduction of 2 H-1,4-Benzoxazines Using Imine Reductases.

Nadine Zumbrägel1, Paul Machui1, Jannis Nonnhoff1, Harald Gröger1.   

Abstract

A biocatalytic reduction of 2 H-1,4-benzoxazines using imine reductases is reported. This process enables a smooth and enantioselective synthesis of the resulting cyclic amines under mild conditions in aqueous media by means of a catalytic amount of the cofactor NADPH as hydride source as well as glucose as the reducing agent used in stoichiometric amounts for in situ cofactor recycling. Several substrates were studied, and the 3,4-dihydro-2 H-1,4-benzoxazines were obtained with up to 99% ee. In addition, the efficiency of this reduction process based on imine reductases as catalysts has been demonstrated for one 2 H-1,4-benzoxazine on an elevated laboratory scale running at a substrate loading of 10 g L-1 in the presence of a tailor-made whole-cell catalyst.

Entities:  

Year:  2019        PMID: 30562025     DOI: 10.1021/acs.joc.8b02867

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Characterization of imine reductases in reductive amination for the exploration of structure-activity relationships.

Authors:  Sarah L Montgomery; Ahir Pushpanath; Rachel S Heath; James R Marshall; Ulrike Klemstein; James L Galman; David Woodlock; Serena Bisagni; Christopher J Taylor; J Mangas-Sanchez; J I Ramsden; Beatriz Dominguez; Nicholas J Turner
Journal:  Sci Adv       Date:  2020-05-22       Impact factor: 14.136

2.  Structural Characterization of an S-enantioselective Imine Reductase from Mycobacterium Smegmatis.

Authors:  Timo Meyer; Nadine Zumbrägel; Christina Geerds; Harald Gröger; Hartmut H Niemann
Journal:  Biomolecules       Date:  2020-07-31

Review 3.  Biocatalytic Reduction Reactions from a Chemist's Perspective.

Authors:  Frank Hollmann; Diederik J Opperman; Caroline E Paul
Journal:  Angew Chem Int Ed Engl       Date:  2020-11-03       Impact factor: 15.336

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.